newsfilter
← Latest News
Business Wire·

Adamas Named 2021 Finalist in the New Therapeutics Category of the UCSF Health Awards

Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced it has been selected as one of five finalists in the UC